The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Feb 2023 13:36

RNS Number : 0478Q
Midatech Pharma PLC
15 February 2023
 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are at- tached ii:

 

Midatech Pharma plc

1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification(please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

S.H.N. Financial Investments

City and country of registered office (if applicable)

Herzliya, Israel

4. Full name of shareholder(s)(if different from 3.) v

Name

City and country of registered office (if applicable)

 

 

5. Date on which the threshold was crossed or reached vi:

15th of February 2023

6. Date on which issuer notified (DD/MM/YYYY):

15th of February 2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights at- tached to shares (to- tal of 8. A)

% of voting rights through financial instru- ments

(total of 8.B 1 + 8.B 2)

 

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A +

8.B) vii

Resulting situation on the date on which

threshold was crossed or reached

 

6.2499

 

0

 

6.2499

 

10834000

Position of previous notification (if applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type of shares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BKT14T00

10834000

6.2499

SUBTOTAL 8. A

10834000

6.2499

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

 

Type of financial in- strument

 

Expiration date x

 

Exercise/ Conversion Period xi

Number of voting rights that may be acquired if the instrument is exercised/converted.

 

% of voting rights

SUBTOTAL 8. B 1

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expiration date x

Exercise/ Conversion Pe- riod xi

Physical or cash Settlement xii

Number of voting rights

 

% of voting rights

SUBTOTAL

8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

x

Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

 

 

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial in- struments if it equals or is higher than the

notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

 

 

Place of completion

UK

Date of completion

15th of February 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLTAMJTMTTBBLJ
Date   Source Headline
14th Aug 20202:05 pmRNSSecond Price Monitoring Extn
14th Aug 20202:00 pmRNSPrice Monitoring Extension
14th Aug 20207:00 amRNSRegistration Statement Declared Effective
10th Aug 20205:36 pmRNSHolding(s) in Company
7th Aug 20207:00 amRNSHolding(s) in Company
6th Aug 20204:54 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHolding(s) in Company
3rd Aug 20203:00 pmRNSHolding(s) in Company
31st Jul 20202:48 pmRNSResult of AGM
30th Jul 202011:00 amRNSPrice Monitoring Extension
30th Jul 20207:00 amRNSHolding(s) in Company
29th Jul 20204:35 pmRNSHolding(s) in Company
27th Jul 20209:40 amRNSBroker Option Fully Exercised
27th Jul 20207:00 amRNSUK Placing to Raise £5.0 million
24th Jul 20201:31 pmRNSHolding(s) in Company
24th Jul 20208:43 amRNSForm 8.3 - Midatech Pharma PLC
23rd Jul 20202:41 pmRNSForm 8.3 - Midatech Pharma plc
23rd Jul 20207:00 amRNSCorporate Update & Formal Sale Process Termination
22nd Jul 20203:25 pmRNSForm 8.3 - Midatech Pharma plc
21st Jul 20202:05 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202011:05 amRNSSecond Price Monitoring Extn
21st Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20209:00 amRNSCollaboration for the Q-Sphera platform
3rd Jul 20205:48 pmRNSPosting of Annual Report & Notice of AGM
3rd Jul 20207:00 amBUSForm 8.3 - Midatech Pharma PLC
30th Jun 20201:37 pmRNSPublication of Annual Report
25th Jun 20203:10 pmRNSHolding(s) in Company
25th Jun 202012:01 pmRNSForm 8.3 - Midatech Pharma PLC
24th Jun 20205:18 pmBUSForm 8.3 - Midatech Pharma plc
24th Jun 202012:01 pmRNSForm 8.3 - Midatech Pharma PLC
18th Jun 20206:25 pmRNSForm 8 (DD) - Midatech Pharma plc
17th Jun 20207:00 amRNSGrant of Options
16th Jun 202010:20 amRNSInvestor Presentation
16th Jun 20207:00 amRNSResults for the year ended 31 December 2019
11th Jun 20203:41 pmRNSForm 8.3 - Midatech Pharma PLC
11th Jun 20203:35 pmRNSForm 8.3 - Midatech Pharma Plc
11th Jun 202010:53 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc (Replacement)
11th Jun 20207:00 amRNSHolding(s) in Company
11th Jun 20207:00 amRNSHolding(s) in Company
10th Jun 20202:00 pmRNSPrice Monitoring Extension
10th Jun 202012:57 pmRNSForm 8.3 - Midatech Pharma plc
10th Jun 202011:00 amRNSPrice Monitoring Extension
9th Jun 20205:35 pmRNSForm 8.3 - Midatech Pharma plc
9th Jun 20204:36 pmRNSPrice Monitoring Extension
9th Jun 20204:04 pmRNSPurported Termination of MTX110 Licence Agreement
9th Jun 20202:48 pmEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma PLC
9th Jun 202012:14 pmRNSForm 8.3 - Midatech Pharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.